Skip to main content

Quality control and quality assurance

  • Chapter
Extravasation of Cytotoxic Agents
  • 998 Accesses

Abstract

Although the extravasation of cytotoxic agents is one of the rarer complications in the context of chemotherapy, it can lead to severe complications when vesicant drugs are involved. Prevention and appropriate treatment are therefore essential, so as to avoid serious sequelae. Quality control and quality assurance are making an appreciable contribution to optimising proceedings in the context of an extravasation event.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Mader, I. (2010). Quality control and quality assurance. In: Extravasation of Cytotoxic Agents. Springer, Vienna. https://doi.org/10.1007/978-3-211-88893-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-88893-3_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-88889-6

  • Online ISBN: 978-3-211-88893-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics